On “Grindeks” results in the first nine months of 2020 - Seite 2

In the first nine months of 2020 sales volume of active pharmaceutical ingredients reached 9,5 million euro, which is by 3,1 million euro or 47% more than in the first nine months of 2019. The largest export countries of “Grindeks” active pharmaceutical ingredients during the reporting period were the EU countries, the USA, Japan and Canada.

In the first nine months of 2020 the subsidiary company of “Grindeks” JSC “Kalceks”, which specializes in medicines for the hospital segment, achieved a rapid increase in sales, achieved by increasing the number of export countries and by introducing new products. JSC “Kalceks” product sales in the first nine months of 2020 reached 31,7 million euro, which is by 23,5 million euro or 3,9 times more than in the first nine months of 2019. In the first nine months of 2020 JSC “Kalceks” medications were exported to 55 countries, main sales markets were Spain, Belgium, Israel, Czech Republic and France.

JSC “Kalceks” has submitted seven new products this year, including Dexamethasone phosphate 4 mg/ml solutions for infusion/injection for registration in 21 European Union countries. According to the results of a study by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), this medicine is indicated for the treatment of coronavirus disease caused by COVID-19 for patients who need oxygen therapy.

About “Grindeks”

“Grindeks” is an international pharmaceutical company focused on research, development, manufacturing and sales of original products, generics and active pharmaceutical ingredients. The Group of “Grindeks” has four subsidiary companies in Latvia, Estonia, and Slovakia as well as representative offices in 11 countries.

“Grindeks” specializes in the heart and cardiovascular, CNS, anti-cancer and anti-diabetes medicines. A range of products covers a combination of original products Mildronate (meldonium*) and Ftorafur, generics and active pharmaceutical ingredients.

In 2019, products of the company were exported to 84 countries. The most important export markets of "Grindeks" are the EU countries, Russia and other CIS countries, the USA, Canada and Japan.

 

Further information:

Laila Klavina

Head of the Communications Department, JSC “Grindeks”

Phones: ([phone], ([phone]

Fax: [phone]

[e-mail]

www.grindeks.lv

Attachment

• Group_Q3_2020_ENG_Financial statements